Inventaire - your friends and communities are your best library

Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis

author

Karin Jensen

1979 -

Irving Kirsch

1943 -

Ted J Kaptchuk

1947 -

Vincent des Portes

published in: PLOS One

date of publication: 2015-07-30

language: English

main subject: disability, placebo, intellectual disability, disability affecting intellectual abilities, meta-analysis

Cites articles 82

Date

Title

Authors

2015-05-18

Down syndrome: Cognitive and behavioral functioning across the lifespan
2014-12-01

A Neural Mechanism for Nonconscious Activation of Conditioned Placebo and Nocebo Responses

Karin Jensen, Martin Ingvar, Irving Kirsch, Ted J Kaptchuk
2014-12-01

Placebo response in antipsychotic clinical trials: a meta-analysis

Jeffrey Lieberman, Melanie Wall
2014-07-22

Harnessing the placebo effect in pediatric migraine clinic

Clas Linnman, David Borsook
2014-03-01

Placebo analgesia: a predictive coding perspective

Stephan Geuter, Falk Eippert, Christian Büchel
2013-09-01

Outcome measures for clinical trials in fragile X syndrome

Allan L. Reiss, Andrea Beckel-Mitchener, David Hessl
2013-09-01

New innovations: therapeutic opportunities for intellectual disabilities

Christopher A. Walsh
2013-01-01

X-linked mental deficiency

Vincent des Portes
2013-04-18

Placebo effects in children: a review

Sibylle Klosterhalfen, Katja Weimer, Angelika Anita Schlarb, Juliane Schwille-Kiuntke, Paul Enck
2013-04-01

A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome

Andrea Schneider, Randi J. Hagerman, Flora Tassone, David Hessl, Susan M. Rivera
2013-06-01

Neurodevelopmental and psychiatric issues in Down's syndrome: assessment and intervention

Maria Pontillo
2013-03-01

The placebo response in medicine: minimize, maximize or personalize?

Paul Enck, Winfried Rief, Ulrike Bingel
2013-03-01

Pharmacologic treatment of pediatric headaches: a meta-analysis

Jeffrey Jackson
2012-09-10

Nonconscious activation of placebo and nocebo pain responses

Irving Kirsch, Ted J Kaptchuk, Chantal Berna, Karin Jensen, Randy L. Gollub, Martin Ingvar
2012-07-17

Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial
2012-01-01

Fragile X syndrome and targeted treatment trials

Randi J. Hagerman
2012-01-10

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial

Dag Aarsland, Ly-Mee Yu, Paul T. Francis, Clive Ballard, Anne Corbett, Nicola Williams, Marisa Hanney
2012-06-29

Effectiveness and safety of donepezil in boys with fragile x syndrome: a double-blind, randomized, controlled pilot study.
2012-11-01

Caregiver placebo effect for dogs with lameness from osteoarthritis.
2012-09-19

A randomised, blinded, crossover study to assess the efficacy of a feed supplement in alleviating the clinical signs of headshaking in 32 horses
2012-05-12

Placebo by proxy: the effect of parents' beliefs on therapy for children's temper tantrums

Michael E. Hyland
2012-09-01

Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial
2011-01-01

Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.

Kimberley Cornish, Fei Chen, Feliciano J Ramos, Nouchine Hadjikhani, Jacques S Beckmann, Vincent des Portes
2011-01-01

Donepezil significantly improves abilities in daily lives of female Down syndrome patients with severe cognitive impairment: a 24-week randomized, double-blind, placebo-controlled trial.
2011-08-11

Placebo by proxy

Ted J Kaptchuk
2010-06-01

Cognitive deficits and associated neurological complications in individuals with Down's syndrome

Mara Dierssen Sotos
2010-02-01

Biological, clinical, and ethical advances of placebo effects

Ted J Kaptchuk, Franklin G. Miller
2010-01-11

Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status
2010-12-01

Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17
2009-04-01

Language Development in Individuals with Fragile X Syndrome

Lizbeth H Finestack
2009-01-01

Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies

Allan L. Reiss
2009-10-01

Direct evidence for spinal cord involvement in placebo analgesia

Christian Büchel, Ulrike Bingel

Article - wd:Q34487591

Welcome to Inventaire

the library of your friends and communities

learn more